ILMN
Illumina IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$19.33B
P/E Ratio
23.20
EPS
$5.45
Beta
1.49
52W High
$155.53
52W Low
$69.29
50-Day MA
$127.08
200-Day MA
$114.96
Dividend Yield
—
Profit Margin
19.60%
Forward P/E
24.81
PEG Ratio
2.32
About Illumina Inc
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California.
Fundamentals
| Revenue (TTM) | $4.34B |
| Gross Profit (TTM) | $2.96B |
| EBITDA | $1.14B |
| Operating Margin | 19.70% |
| Return on Equity | 33.40% |
| Return on Assets | 8.39% |
| Revenue/Share (TTM) | $28.02 |
| Book Value | $17.80 |
| Price-to-Book | 7.15 |
| Price-to-Sales (TTM) | 4.45 |
| EV/Revenue | 4.696 |
| EV/EBITDA | 14.00 |
| Quarterly Earnings Growth (YoY) | 86.40% |
| Quarterly Revenue Growth (YoY) | 5.00% |
| Shares Outstanding | $152.90M |
| Float | $148.61M |
| % Insiders | 0.23% |
| % Institutions | 106.87% |
Analyst Ratings
Consensus ($136.11 target)
1
Strong Buy8
Buy7
Hold1
Sell2
Strong SellData last updated: 4/8/2026